NIFTY 50

Aurobindo Pharma unit gets warning letter from USFDA

Updated : July 03, 2019 12:21 PM IST

Three of Aurobindo's units had received an official action indicated status from the USFDA in May but now, Unit XI has been downgraded with a warning letter.
The warning letter is centered on the issue of the manufacture of Valsartan API.

You May Also Like

Live TV